Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study.
Rosati G, Pinto C, Di Fabio F, Chiara S, Lolli IR, Ruggeri EM, Ciuffreda L, Ferrara R, Antonuzzo L, Adua D, Racca P, Bilancia D, Benincasa E, Stroppolo ME, Di Costanzo F. Rosati G, et al. Among authors: ferrara r. J Geriatr Oncol. 2018 May;9(3):243-248. doi: 10.1016/j.jgo.2018.01.009. Epub 2018 Feb 9. J Geriatr Oncol. 2018. PMID: 29433905 Free article.
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.
Pinto C, Di Fabio F, Rosati G, Lolli IR, Ruggeri EM, Ciuffreda L, Ferrari D, Lo Re G, Rosti G, Tralongo P, Ferrara R, Alabiso O, Chiara S, Ianniello GP, Frassoldati A, Bilancia D, Campanella GA, Signorelli C, Racca P, Benincasa E, Stroppolo ME, Di Costanzo F. Pinto C, et al. Among authors: ferrara r. Cancer Med. 2016 Nov;5(11):3272-3281. doi: 10.1002/cam4.888. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748041 Free PMC article.
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant.
Sacchi S, Marcheselli R, Lazzaro A, Morabito F, Fragasso A, Di Renzo N, Balleari E, Neri S, Quarta G, Ferrara R, Vigliotti ML, Polimeno G, Musto P, Consoli U, Zoboli A, Buda G, Pastorini A, Masini L. Sacchi S, et al. Among authors: ferrara r. Leuk Lymphoma. 2011 Oct;52(10):1942-8. doi: 10.3109/10428194.2011.584006. Epub 2011 Jun 12. Leuk Lymphoma. 2011. PMID: 21663513 Clinical Trial.
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.
Silvestris N, Pantano F, Ibrahim T, Gamucci T, De Vita F, Di Palma T, Pedrazzoli P, Barni S, Bernardo A, Febbraro A, Satolli MA, Bertocchi P, Catalano V, Giommoni E, Comandone A, Maiello E, Riccardi F, Ferrara R, Trogu A, Berardi R, Leo S, Bertolini A, Angelini F, Cinieri S, Russo A, Pisconti S, Brunetti AE, Azzariti A, Santini D. Silvestris N, et al. Among authors: ferrara r. PLoS One. 2013 Oct 28;8(10):e74402. doi: 10.1371/journal.pone.0074402. eCollection 2013. PLoS One. 2013. PMID: 24204569 Free PMC article.
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Aglietta M, Montemurro F, Fagioli F, Volta C, Botto B, Cantonetti M, Racanelli V, Teofili L, Ferrara R, Amadori S, Castoldi GL, Dammacco F, Levis A. Aglietta M, et al. Among authors: ferrara r. Cancer. 2000 Jan 15;88(2):454-60. doi: 10.1002/(sici)1097-0142(20000115)88:2<454::aid-cncr28>3.0.co;2-q. Cancer. 2000. PMID: 10640980 Clinical Trial.
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.
Ogliari FR, Traverso A, Barbieri S, Montagna M, Chiabrando F, Versino E, Bosco A, Lin A, Ferrara R, Oresti S, Damiano G, Viganò MG, Ferrara M, Riva ST, Nuccio A, Venanzi FM, Vignale D, Cicala G, Palmisano A, Cascinu S, Gregorc V, Bulotta A, Esposito A, Tacchetti C, Reni M. Ogliari FR, et al. Among authors: ferrara r. Lung Cancer. 2024 Dec 31;199:108075. doi: 10.1016/j.lungcan.2024.108075. Online ahead of print. Lung Cancer. 2024. PMID: 39752796
Persistence, severity and reactivity thresholds in fish allergic patients sensitized to parvalbumin.
Vera-Berrios RN, Vázquez-Cortés S, Gonzalo-Fernández A, Bindslev-Jensen C, Clausen M, Ferrara R, Gunnbjornsdottir M, Jongejan L, Lewandowska-Polak A, Mari A, Papadopoulos N, Poulsen LK, Prado ND, Magadán SS, Schnoor H, Stavroulakis G, Versteeg SA, Witten M, van Ree R, Fernández-Rivas M. Vera-Berrios RN, et al. Among authors: ferrara r. J Allergy Clin Immunol Pract. 2024 Dec 26:S2213-2198(24)01275-3. doi: 10.1016/j.jaip.2024.12.026. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39732287
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes.
Bertolaccini L, Tralongo AC, Del Re M, Facchinetti F, Ferrara R, Franchina T, Graziano P, Malapelle U, Menis J, Passaro A, Pilotto S, Ramella S, Rossi G, Trisolini R, Cinquini M, Passiglia F, Novello S. Bertolaccini L, et al. Among authors: ferrara r. Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21. Lung Cancer. 2024. PMID: 39461280
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.
D'Ambrosio S, Salomone F, Vitale F, Avanzo A, Viggiano A, Liguori L, Ferrara R, Nuccio A, Viscardi G, Napolitano F, Santaniello A, Formisano L, Bianco R, Servetto A. D'Ambrosio S, et al. Among authors: ferrara r. Eur J Cancer. 2024 Dec;213:115077. doi: 10.1016/j.ejca.2024.115077. Epub 2024 Oct 20. Eur J Cancer. 2024. PMID: 39454538 Free article.
365 results